Istradefylline (KW-6002)
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Sleep Disorder
Conditions
Sleep Disorder, Restless Legs Syndrome
Trial Timeline
Jul 1, 2005 → Oct 1, 2006
NCT ID
NCT00199446About Istradefylline (KW-6002)
Istradefylline (KW-6002) is a phase 2 stage product being developed by Kyowa Kirin for Sleep Disorder. The current trial status is completed. This product is registered under clinical trial identifier NCT00199446. Target conditions include Sleep Disorder, Restless Legs Syndrome.
What happened to similar drugs?
20 of 20 similar drugs in Sleep Disorder were approved
Approved (20) Terminated (2) Active (0)
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (8)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00250393 | Phase 2 | Completed |
| NCT00199446 | Phase 2 | Completed |
| NCT00199433 | Phase 2 | Completed |
| NCT00199355 | Phase 2 | Completed |
| NCT00199394 | Phase 3 | Completed |
| NCT00199420 | Phase 3 | Completed |
| NCT00199407 | Phase 3 | Completed |
| NCT00456794 | Phase 2 | Completed |
Competing Products
20 competing products in Sleep Disorder